-
Featured
Mass General Surgeons Pioneer Transplant Surgery with DCD Donor Hearts
The first-ever heart transplant using a donation after circulatory death (DCD) donor heart in New England was recently performed at Massachusetts General Hospital.
-
Featured
Innovation Increases Availability of Hearts and Lungs for Transplant
Warm perfusion and careful selection of marginal organs allow Mass General transplant teams to save more lives.
-
Driving Pig Organ Xenotransplantation Towards Clinical Trials
Massachusetts General Hospital research is driving improved results in preclinical xenotransplantation models, paving the way for future human clinical trials.
-
Ex Vivo Perfusion and Transplantation of Hearts Donated After Circulatory Death Is Safe and Effective
Massachusetts General Hospital researchers found transplantation of hearts donated after circulatory death and preserved with a proprietary ex vivo warm perfusion system was safe and effective compared with control subjects who received hearts donated after brain death. The one-year survival rate was 97%.
-
TCS–VAD Better Than ECMO for Acute Support Before Heart Transplantation
In a nationwide study, patients bridged to transplant with temporary circulatory support–ventricular assist devices had post-transplant survival superior to those bridged with extracorporeal membrane oxygenation and similar to those bridged with left-ventricular assist devices.
-
DCD Donor Hearts Safely Expand Donor Organ Pool
Massachusetts General Hospital is one of five donation after circulatory death (DCD) heart transplant centers in the U.S., investigating DCD donor hearts for transplantation.
Heart Transplant Contributors
-
David A. D'Alessandro, MD
Surgical Director, Heart Transplantation and Ventricular Assist Devices, Member of Faculty, Harvard Medical School
Recent Article
Ex Vivo Perfusion and Transplantation of Hearts Donated After Circulatory Death Is Safe and Effective -
Gregory D. Lewis, MD
Jeffrey and Mary Ellen Jay Chair and Section Head of Heart Failure, Medical Director of Heart Transplantation
Recent Article
Higher Peak Systolic BP on Exercise Testing May Not Indicate Adverse Vascular Function -
James F. Markmann, MD, PhD
Chief, Division of Transplantation, Massachusetts General Hospital, Surgical Director, Liver, Pancreas and Islet Transplant Programs, Clinical Director, MGH Transplant Center, Claude E. Welch Professor of Surgery, Harvard Medical School
Recent Article
Mass General Surgeons Pioneer Transplant Surgery with DCD Donor Hearts